Auteur F. M. ORSON

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Anti-cocaine vaccine development

B. M. KINSEY ; T. R. KOSTEN ; F. M. ORSON | 2010
Périodique

Cocaine abuse is an ongoing and serious problem that has led to the growth of a brutal criminal enterprise, particularly in the Americas and Europe. At present, there are no effective pharmacological agents available to treat the addiction by bl[...]

Plus d'info

Ajouter à la sélection

Lien externe

Cocaine vaccine for the treatment of cocaine dependence in methadone maintained patients: a randomized double bind placebo controlled efficacity trial

B. A. MARTELL ; F. M. ORSON ; J. POLING ; E. MITCHELL ; R. D. ROSSEN ; T. GARDNER ; T. R. KOSTEN | 2009
Périodique

CONTEXT. Cocaine dependence, which affects 2.5 million Americans annually, has no US Food and Drug Administration–approved pharmacotherapy. OBJECTIVES. To evaluate the immunogenicity, safety, and efficacy of a novel cocaine vaccine to treat coc[...]

Plus d'info

Ajouter à la sélection

Lien externe

Substance abuse vaccines

F. M. ORSON ; B. M. KINSEY ; R. A. SINGH ; Y. WU ; T. GARDNER ; T. R. KOSTEN | 2008
Périodique

Conventional substance-abuse treatments have only had limited success for drugs such as cocaine, nicotine, methamphetamine, and phencyclidine. New approaches, including vaccination to block the effects of these drugs on the brain, are in advance[...]

Plus d'info

Ajouter à la sélection

Lien externe

Vaccines against drug abuse

X. Y. SHEN ; F. M. ORSON ; T. R. KOSTEN | 2012
Dans Clinical Pharmacology and Therapeutics (Vol.91, n°1, January 2012) Article : Périodique

The currently available medications for the treatment of drug abuse have had only limited success. Anti-addiction vaccines, aimed at eliciting antibodies that block the pharmacological effects of drugs, have great potential for treating drug abu[...]

Plus d'info

Ajouter à la sélection